COVID-19 Vaccination Rates in a Global HIV Cohort

Abstract Little is known regarding coronavirus disease 2019 (COVID-19) vaccination rates in people with HIV (PWH), a vulnerable population with significant morbidity from COVID-19. We assessed COVID-19 vaccination rates among 6952 PWH in the Randomized Trial to Prevent Vascular Events in HIV (REPRIE...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases 2022-02, Vol.225 (4), p.603-607
Main Authors: Fulda, Evelynne S, Fitch, Kathleen V, Overton, Edgar T, Zanni, Markella V, Aberg, Judith A, Currier, Judith S, Lu, Michael T, Malvestutto, Carlos, Fichtenbaum, Carl J, Martinez, Esteban, Umbleja, Triin, Douglas, Pamela S, Ribaudo, Heather J, Grinspoon, Steven K
Format: Article
Language:English
Subjects:
Body mass index
Cardiovascular diseases
Clinical trials
Coronaviruses
COVID-19
COVID-19 - prevention & control
COVID-19 vaccines
COVID-19 Vaccines - administration & dosage
HIV
HIV Infections - therapy
Human immunodeficiency virus
Humans
Immunization
Major and Brief Reports
Male
Morbidity
Randomized Controlled Trials as Topic
Vaccination
Vaccination - statistics & numerical data
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Little is known regarding coronavirus disease 2019 (COVID-19) vaccination rates in people with HIV (PWH), a vulnerable population with significant morbidity from COVID-19. We assessed COVID-19 vaccination rates among 6952 PWH in the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) compared to region- and country-specific vaccination data. The global probability of COVID-19 vaccination through end of July 2021 was 55% among REPRIEVE participants with rates varying substantially by Global Burden of Disease (GBD) superregion. Among PWH, factors associated with COVID-19 vaccination included residence in high-income regions, age, white race, male sex, body mass index, and higher cardiovascular risk. Clinical Trials Registration. NCT02344290.
ISSN:0022-1899
1537-6613
DOI:10.1093/infdis/jiab575